SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023. “We shipped five G4…Read More
Singular Genomics Systems Inc Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
